Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam M Murray

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Vaccine|March 27, 2021
Chlamydia trachomatis: Cell biology, immunology and vaccinationSam M Murray, Paul F McKay
NPJ Vaccines|May 14, 2021
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2Ian McDonald, Sam M Murray, Catherine J Reynolds, et al.
Nature Reviews. Immunology|December 20, 2022
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responsesSam M Murray, Azim M Ansari, John Frater, et al.
Current Treatment Options in Oncology|August 23, 2021
Immunotherapy in Hepatocellular CarcinomaClaudia A M Fulgenzi, Thomas Talbot, Sam M Murray, et al.
Science Immunology|August 29, 2025
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccinesSam M Murray, Ali Amini, Helen Ferry, et al.
British Journal of Haematology|June 3, 2022
Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplantSam M Murray, Maria Barbanti, Cori Campbell, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.
The Lancet. Microbe|April 26, 2025
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of responsePhilip G Drennan, Nicholas M Provine, Stephanie A Harris, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Vaccine|March 27, 2021
Chlamydia trachomatis: Cell biology, immunology and vaccinationSam M Murray, Paul F McKay
NPJ Vaccines|May 14, 2021
Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2Ian McDonald, Sam M Murray, Catherine J Reynolds, et al.
Nature Reviews. Immunology|December 20, 2022
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responsesSam M Murray, Azim M Ansari, John Frater, et al.
Current Treatment Options in Oncology|August 23, 2021
Immunotherapy in Hepatocellular CarcinomaClaudia A M Fulgenzi, Thomas Talbot, Sam M Murray, et al.
Science Immunology|August 29, 2025
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccinesSam M Murray, Ali Amini, Helen Ferry, et al.
British Journal of Haematology|June 3, 2022
Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplantSam M Murray, Maria Barbanti, Cori Campbell, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.
The Lancet. Microbe|April 26, 2025
Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective, single-centre, cohort study and analysis of transcriptomic predictors of responsePhilip G Drennan, Nicholas M Provine, Stephanie A Harris, et al.
Science Immunology|August 29, 2025
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccinesAli Amini, Lucy C Garner, Robert H Shaw, et al.
Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.
Pageof 2